Himisha Beltran, MD is a genitourinary (GU) medical oncologist at the Dana-Farber Cancer Institute (DFCI) and Associate Professor of Medicine at Harvard Medical School. She also serves as Director of Translational Research within Medical Oncology at DFCI, Co-Director of the DFCI Center for Cancer Genomics (CCG), and Co-Director of the Dana-Farber/Harvard Cancer Center NCI SPORE in Prostate Cancer. Dr. Beltran’s clinical practice and research focus on advanced prostate cancer. Her lab studies mechanisms of treatment resistance in prostate cancer and has developed therapeutic targets and biomarkers for non-androgen receptor driven prostate cancer including neuroendocrine prostate cancer (NEPC), an aggressive subtype of castration resistant prostate cancer. Dr. Beltran also leads clinical trials and serves as Correlative Science Chair for the Alliance Cooperative Group GU Committee.